College of Pharmacy Associate Professors, Melanie Dodd, PharmD and Joe Anderson, PharmD have been awarded a grant from Novartis Pharmaceuticals for the MTM Pilot project that is being conducted under the auspices of the New Mexico Prescription Improvement Coalition. The have received funding for $119,815 from Novartis, $25,000 from Merck, $25,000 from Presbyterian Health Plan, $90,000 from the National Association of Community Drug Stores Foundation, and in-kind services from several others such as ~$10,000 from Lovelace Health Plan. The primary objective is to evaluate the effectiveness of face-to-face MTM as compared to the prescription drug plan’s usual method of MTM on medication adherence. Secondary objectives include disease-specific clinical outcomes, quality of life, satisfaction with care, and resource utilization, and a cost-effectiveness analysis between face-to-face and usual MTM. Community pharmacists throughout New Mexico (Farmington, Las Cruces, Artesia, Las Vegas, Española, Taos, Estancia, Truth or Consequences, Clovis, and Albuquerque) will be participating in this important study. Dr. Dodd is the Project Director and Dr. Anderson is the Co-Director.
The University of New Mexico’s Doctor of Pharmacy program is accredited by the Accreditation Council for Pharmacy Education, 20 North Clark Street, Suite 2500, Chicago, IL 60602-5109, TEL (312) 664-3575 , FAX (312) 664-4652, URL http://www.acpe-accredit.org/
02/15/2011 12:05:56 PM -0700.